DealKorsana Biosciences, Inc., a Waltham, MA-based Alzheimer’s antibody developer, raised $175 million in a Seed and Series A fundraising round led by Wellington Management and TCG Crossover with participation from Fairmount.
More on STAT+ →
SERIES A
02/21/2026
Flourish Care, a Boston-based women’s mental health platform, raised...
NanoZymeX, a Basel, Switzerland-based nanobiotech enzyme therapy platform,...
Cellbricks Therapeutics, a Berlin, Germany-based biofabricated tissue...
Ouro Medicines, a Cambridge, MA-based clinical-stage immunology biotech,...
Bioniq, a London-based personalised health platform, was acquired for $150...
Terns Pharmaceuticals, Inc., a Foster City, CA-based leukemia therapy...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
